Simon Moroney

Type: Person
Name: Simon Moroney
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

MorphoSys in prostate cancer deal

MorphoSys AG has broadened its portfolio of oncology assets with an agreement to in-license a candidate bispecific antibody targeting prostate cancer, one of the most common cancers in men. The deal, with Emergent BioSolutions Inc of the US, involves ... [Published MedNous - Aug 20 2014]

More Content

All (1) | News (1) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
MorphoSys in prostate cancer deal [Published MedNous - Aug 20 2014]
Content Volume
Document Volume
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.